Form D · Biotechnology

Analyte Logic Corp

Denver, CO · CIK 0001527054

Offering snapshot reported Jan 27, 2014 · SEC filing

Reported sold
$700K
Offering amount: $1.25M
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 5, 2011
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$350K$700KAug 1, 2011: $100,000.00Aug 1, 2011Jul 26, 2012: $250,000.00Jul 26, 2012Sep 18, 2012: $350,000.00Jan 27, 2014: $700,000.00Jan 27, 2014

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$350,000 → $700,000
  • Reported investors7 → 11

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 27, 2014Amendment$700,000$350,000vs Sep 18, 201211SEC filing
Sep 18, 2012Amendment$350,000$100,000vs Jul 26, 20127SEC filing
Jul 26, 2012Amendment$250,000$150,000vs Aug 1, 20115SEC filing
Aug 1, 2011Initial$100,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-163718

Source: Form D, filed Jan 27, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Nicholas Taro Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
8771 East 29 Th Avenue
Denver, CO, 80238